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Abstract. Breast conserving surgery (BCS) is an effective treatment for early-stage cancers as long as
the margins of the resected tissue are free of disease according to consensus guidelines for patient manage-
ment. However, 15% to 35% of patients undergo a second surgery since malignant cells are found close to or at
the margins of the original resection specimen. This review highlights imaging approaches being investigated to
reduce the rate of positive margins, and they are reviewed with the assumption that a new system would need
high sensitivity near 95% and specificity near 85%. The problem appears to be twofold. The first is for complete,
fast surface scanning for cellular, structural, and/or molecular features of cancer, in a lumpectomy volume, which
is variable in size, but can be large, irregular, and amorphous. A second is for full, volumetric imaging of the
specimen at high spatial resolution, to better guide internal radiologic decision-making about the spiculations and
duct tracks, which may inform that surfaces are involved. These two demands are not easily solved by a single
tool. Optical methods that scan large surfaces quickly are needed with cellular/molecular sensitivity to solve the
first problem, but volumetric imaging with high spatial resolution for soft tissues is largely outside of the optical
realm and requires x-ray, micro-CT, or magnetic resonance imaging if they can be achieved efficiently. In sum-
mary, it appears that a combination of systems into hybrid platforms may be the optimal solution for these two
very different problems. This concept must be cost-effective, image specimens within minutes and be coupled to
decision-making tools that help a surgeon without adding to the procedure. The potential for optical systems to
be involved in this problem is emerging and clinical trials are underway in several of these technologies to see if
they could reduce positive margin rates in BCS. © 2018 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1
.JBO.23.10.100901]
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1 Introduction
Technologies currently available for breast imaging offer high
sensitivity and specificity, but they have been developed largely
for the tasks of screening and presurgical planning. The most
common clinical modality for breast imaging is x-ray mammog-
raphy, which has an estimated sensitivity of between 83% and
95% and an estimated specificity of between 90% and 98%.1 In
comparison, imaging tools for inspection of surgical cavities or
resected specimens are much less well developed. In this paper,
technologies for detection and imaging of surgical specimens
are reviewed in order to highlight clinical needs and potential
value in terms of breast cancer management.
Breast malignancy is the second most prevalent cancer diag-
nosis for women in the United States with 1 out of every 8
women being diagnosed with the disease during a lifetime.
In the United States, nearly 250,000 new cases are diagnosed
each year and more than 40,000 women will die from breast
cancer annually.2 The recommended treatment for early-stage
disease is breast conserving surgery (BCS). This procedure
seeks to remove the cancer with a margin of normal tissue sur-
rounding the resected specimen. In many cases, BCS is followed
by chemotherapy and/or radiotherapy. Long-term outcomes of
BCS are equivalent to mastectomy for early stage breast cancers
if clear margins are obtained during the process.3
Current consensus guidelines define a surgical margin as
negative if no malignant cells are observed at the surface of
the resected specimen for invasive cancers.4 The judgement
of “no tumor on ink” is used to indicate that the inked borders
are free from any detectable tumor tissue. For ductal carcinoma
in situ (DCIS), a clear margin of 2 mm is now recommended.5
About 20% to 40% of BCS procedures result in margins, which
are either positive or close to having cancer on the surface of the
tissue and require a second operation to remove more tissue.6–9
The high percentage of re-excisions leads to additional costs,
additional anxiety for patients, and an increased risk of postsur-
gical complications (e.g., infection). Thus improved imaging
tools are needed to ensure clear margins at the time of BCS;
and hence, the motivation to review state-of-the-art intrasurgical
tools for margin assessment during BCS. Although other studies
have reviewed the literature of margin management in BCS, the
focus has been more around the surgical procedure choices
rather than the imaging technologies possible.10,11 This review
focuses on the latter issue of what technologies would be opti-
mal for the problem.
Ideally, a system to improve positive margin detection would
have an extremely high sensitivity in order to accurately detect
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all tumor found in the margins, with a sensitivity of above 95%.
Specificity would be less important, because detection is the pri-
mary concern in this setting, but excess false positive detection
would ultimately be detrimental to the system and its use, and so
it is likely needed to be about 85% in an ideal situation. An alter-
native view though is that current practice of a surgeon making the
decision where to end the resection has a specificity of about 65%
to 85%, based upon the recall rate from BCS surgery (35% to 15%
depending upon the center), and so a system should have a speci-
ficity at least matching the best practices today, at 85%.12–15
Figure 1 shows a conceptual flowchart, indicating where im-
aging is involved in breast healthcare, with screening methods
appearing at the top in blue, and invasive/diagnostic methods in
green. The range of imaging/detection tools for intrasurgical use
appears in yellow and is categorized by technology subtype.
This part of the figure summarizes a number of different
forms of imaging, in which studies involving human specimens
from BCS have been reported. Each of these methods is dis-
cussed in detail. Methods appearing in bold font are either
FDA approved for margin detection in BCS or are part of stan-
dard-of-care during surgery. This figure conveys the general
workflow of imaging for breast cancer beginning with surveil-
lance via screening mammography followed by diagnostic
workup (in blue) when imaging abnormalities are found leading
to surgical planning (green) and intraoperative imaging (in yel-
low) once a definitive cancer diagnosis occurs and BCS is
chosen for treatment.
2 Preoperative Imaging
Although this review focuses on imaging techniques used intra-
operatively, the other major uses of imaging in, and leading up
to, BCS are summarized. Clearly, the most widely accepted im-
aging tool for breast cancer screening is x-ray mammography
because of the legislated and clinically prescribed screening pro-
grams currently in place that have contributed to reduced mortal-
ity rates of the disease. Annual screening is recommended for
women aged 50 to 74 and sometimes for women in the age range
40 to 49 based on patient history, although the guideline is sub-
ject to debate,16 individual differences (e.g., family history)
often come into play.17 Screening mammography involves
low-energy x-ray projections to image the compressed breast
and resulting data are read by a radiologist for local
abnormalities.18 In some geographic locations and for certain
groups of women, x-ray tomosynthesis may be used instead
to create quasi-3-D or multiple 2-D views that mitigate the read-
ing challenges presented by tissue overlap, which can be espe-
cially difficult in dense breast tissue.19 Additionally, women
with dense breasts are offered 3-D ultrasound screening in
some locations, to ensure that the process is as sensitive as pos-
sible at finding abnormalities.20,21 For women with a strong
familiar disposition or other high-risk factors, magnetic reso-
nance imaging (MRI) is the preferred screening tool.22,23
If an abnormality is found, diagnostic workup and biopsy
may occur to determine the origin of the tissue and provide
a definitive diagnosis. Diagnostic workup often includes addi-
tional mammography at higher dose but with superior clarity,
spot x-ray mammograms, 3-D tomosynthesis, 3-D or 2-D ultra-
sound, and/or contrast-enhanced MRI. Selections from these
methods depend on findings from previous tests and the
patient’s data.24–26 Each of these methods may be used to
guide biopsy or occur during a subsequent biopsy procedure
to obtain tissue for pathology processing. Pathological diagnosis
Fig. 1 Imaging as part of breast cancer surveillance/diagnosis (blue) and therapy (green) is illustrated.
Intraoperative imaging tools (yellow), which have been attempted for margin assessment in BCS, are
discussed.
Journal of Biomedical Optics 100901-2 October 2018 • Vol. 23(10)
Maloney et al.: Review of methods for intraoperative margin detection for breast conserving surgery
Downloaded From: https://www.spiedigitallibrary.org/journals/Journal-of-Biomedical-Optics on 26 Jul 2019
Terms of Use: https://www.spiedigitallibrary.org/terms-of-use
is performed on formalin-fixed and stained tissues, with optional
FISH and immunohistochemical stain readings.
Imaging is also used for BCS planning. Examples include
radiological biopsies, presurgical CT, x-ray-guided wire place-
ment and localization, ultrasound for tumor localization, and




Histology methods for margin detection assess the microscopic
cellular structure of tissue. These approaches are slower
than other imaging techniques and are usually more labor inten-
sive. They are also the most well established and currently serve
as the gold standard for comparisons with other detection
approaches.
The current gold standard for margin classification is pro-
vided by a surgical pathologist, after surgery. Tissue is fixed,
processed, sectioned, stained with hematoxylin and eosin
(H&E), and interpreted microscopically. Although the approach
is accurate, it is also time consuming and is completed over sev-
eral days after the original surgery, depending on the specimen
size and diagnostic complexity. If positive or close margins are
found, then a second surgical procedure may need to be per-
formed. This outcome leads to additional stress for the patient,
costs to healthcare system, potentially suboptimal cosmesis and
increased risk of surgical infection from the re-excision.
3.1.1 Frozen sectioning
Frozen sectioning is the most commonly used method for intra-
operative margin assessment during BCS and is considered stan-
dard-of-care in some hospitals.31 Frozen section analysis
consists of freezing small pieces of tissue, then sectioning, stain-
ing, and interpreting them under a microscope. The time from
the tissue leaving the operating room (OR) and a microscopic
diagnosis being rendered is 20 to 30 min, during which period
the patient remains under anesthesia. Freezing tissue generates
significant artifacts, especially in fatty tissues, such as the breast.
It can also be damaging such that tissue used for frozen section-
ing may not be viable for the routine histopathologic margin
assessment performed later. Frozen section interpretations are
expensive and require additional technical staff to cut the spec-
imens. These limitations result in a small fraction of the speci-
men margin being frozen and analyzed, leaving a large
percentage of the tissue unassessed. Frozen sectioning was
also found to be slightly less effective for DCIS and larger
tumors. Frozen sectioning has been shown to reduce positive
margin rates, but not eliminate them.32–34 This technique has
a sensitivity of 83% and a specificity of 95%.35 Frozen section
analysis produces information similar to that found in standard
histology at a much faster rate. However, it is not the ideal sol-
ution to the margin issue in BCS due to its low sampling per-
centage, large technical issues, and high cost.
3.1.2 Imprint cytology
Imprint cytology is another pathology-based margin detection
method used as a standard-of-care during BCS. Here each sur-
face of a resected specimen is positioned and pressed into a slide
which is then fixed and stained. The method is based on the idea
that malignant cells will stick to the slides, whereas adipose cells
will not adhere. It offers similar accuracy and predictive value as
frozen sectioning while taking less time (about 15 rather than
30 min) and being less damaging to the tissue. Imprint cytology
also examines the entire surface of the resected tissue rather than
only the spot checks that occur with frozen sectioning. However,
rapid and accurate interpretation requires a cytopathology-
trained professional in the OR in addition to the regular surgical
staff and relies on subspecialist diagnostic skills as well.32
Varying results have also been obtained when the surface of
the resected tissue has been altered by cauterization and dryness.
Over interpreting atypical cells at the surface that are not malig-
nant may also be problematic.36 This technique has a sensitivity
of 72% and a specificity of 97%.35 Imprint cytology has strong
aspects in that it samples the entire surface of the sample rapidly
and offers similar information to standard histology. However,
its low sensitivity, need for a trained cytopathologist, and vari-
ous artifacts prevent it from being an ideal solution.
3.2 X-Ray Imaging
Contrast from x-ray attenuation of fibroglanduar versus adipose
tissue is high, whereas differences between tumors and fibro-
glandular tissues are more subtle. Further, higher-keV x-rays
(50 to 60 keV) offer better penetration into tissue but lower-
keV x-rays (15 to 25 keV) generate superior contrast for imag-
ing internal structures. Table 1 summarizes several x-ray imag-
ing systems for resected specimen scanning in terms of their
technical specifications (field of view, resolution, focal spot,
energy range, and footprint).37–41
3.2.1 Radiographic imaging (projections)
Radiographic approaches exploit 2-D x-ray projections to image
tissue and produce contrast based on beam attenuation through
the tissue. Standard-of-care involves using these x-ray projec-
tions to guide placement of a surgical wire to localize the center
of the apparent lesion and verify that the lesion appears to be
contained within the specimen. A study compared intraoperative
digital specimen mammography to standard specimen
radiography.42 Both methods were evaluated for tumor localiza-
tion and margin estimation, although standard specimen mam-
mography is performed outside the OR environment, so it
involves removing the resected tissue from the OR and trans-
porting it to another location to perform the imaging. The
study found that digital specimen mammography produced
comparable results in the OR.42 Another study found that intra-
operative digital specimen mammography did not reduce oper-
ation times compared to convention specimen mammography as
one might expect but that it did lead to a significant reduction in
positive margins.43 Intraoperative x-ray imaging is done using
digital mammography, which uses a solid-state detector to
increase the dynamic range of the system. Beam parameters
are able to be optimized for different thicknesses of breast.
One study found that for smaller breasts (21- to 32-mm in thick-
ness) a 25- or 28-kV Mo/Mo target/filter setting was found to be
optimal and for breasts with thicknesses >45 mm, a 34-kV
beam with Rh/Rh target/filter was ideal.44
Often, multiple radiographic images are acquired in orthogo-
nal 2-D views to obtain 3-D information.45 In a recent study,
intraoperative specimen radiography yielded a sensitivity of
41% and a specificity 78% with 2-D imaging and a sensitivity
of 47% and a specificity of 75% with 3-D imaging for positive
margins.46 Although the addition of specimen radiography
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lowered the number of re-excisions, it also generated a large
number of false positives that led to unnecessary tissue removal.
Interestingly, only a small increase in the number of re-excisions
was found if 3-D radiographic imaging was used instead of its
2-D counterpart with the Faxitron Biosystem and wedge tissue
holding system.46 Another study investigated digital breast
tomosynthesis relative to digital mammography and found
the former was better at identifying regions of invasive cancer,
particularly in the vertical plane of the tomosynthesis data.
These tomosynthesis data use x-ray projections at different
angles to obtain 3-D information and create an image stack
of thin slices of cross-sectional images rather than orthogonal
images such as those shown earlier in this review.47
This type of x-ray imaging is conventionally accepted and is
the same technology (mammography and tomosynthesis) used
for in vivo breast imaging. It provides volumetric image data
with good fat/tissue contrast, and therefore, is readily interpreted.
The subtleties of radiological reading of these images are also
well developed, and providing a radiology consult to OR person-
nel when needed has been worked out in most medical centers.
Additionally, presurgical mammo/tomo images can be com-
pared directly to the specimen mammo/tomo results, allowing
for improved interpretation of resection accuracy. Limitations
include lack of specificity for tumor versus dense fibroglandular
tissue, which diminish accuracy for margin assessment.
3.2.2 Micro-CT (3-D volumes)
One form of radiographic projection imaging of particular inter-
est is micro-CT. Micro-CT uses x-ray projections in the same
manner as convention CT, however, it is designed to have
much higher resolution in the micrometer scale. This is impor-
tant since the resolution needed to confirm margin status and the
shape of microcalcifications leading to the margins in resected
specimens is on this spatial scale. Micro-CT has been used in
several studies to image resected tumor tissues, shaved cavity
margins, and auxiliary lymph nodes in BCS. Micro-CT captures
x-ray projections at many angles (typically 180) to create a volu-
metric dataset. Accordingly, micro-CT recovers higher soft tis-
sue contrast because of the acquisition of multiple beam angles
and use of filtered back projection reconstruction. The 3-D
image volume can be used to identify tumor location in resected
specimens or shaved cavity margins. Micro-CT may also be use-
ful in lymph node analysis and assessment of mastectomy spec-
imens. Figure 2 shows an example illustrating more accurate
estimation of tumor distance from the specimen edge with
micro-CT relative to 2-D radiography.48 Investigations of
micro-CT as a predictor of whether breast microcalcifications
indicate malignant or benign conditions at the tissue surface
are underway because the approach provides 3-D shape analysis
at sufficient spatial resolution. These microcalcifications can be
used to determine which margins are most likely to contain a
positive margin.49,50 Micro-CT has also been combined with
other types of imaging systems such as spatial frequency domain
imaging (SFDI) to create multidimensional data that may offer
accurate specimen margin assessments.51 A recent study of fresh
lumpectomy specimens was able to identify the correct margin
status on 25 out of 29 patients that were able to be analyzed.
There were four false negative results which lead to a sensitivity
of 56% and a specificity of 100%.52 Another recent study of 32
patients yielded a sensitivity of 60% and a specificity of 67%.53
Micro-CT generates volumetric data with reasonably high-
soft tissue contrast, which is its main advantage over 2-D
x-ray projection imaging. Imperfect discrimination between
tumor and fibroglandular/dense tissue still occurs and limits
completely accurate margin assessment of specimens.
Additionally, the acquisition of multiple beam angles of data,
image reconstruction, and the need to read/diagnose the volu-
metric 3-D results requires more time than 2-D imaging.
3.3 Magnetic Resonance Imaging
MRI applies high magnetic fields (0.1 to 7 Tesla) with
sequenced radiofrequency signals to recover images of the
Table 1 Technical specifications of x-ray systems used for specimen margin analysis during BCS in published studies.37–41 The imaging areas,
spatial resolution all dramatically affect the imaging time, and so comparisons on all three of these issues is challenging. But in general imaging full
specimens on a timescale near a minute or less is possible for both x-ray and micro-CT with spatial resolution near 10 to 20 μm.
System Faxitron Biovision+ Faxitron Biovision Hologic trident
Perkin Elmer IVIS
spectrumCT Bruker Skyscan 1173




x-ray cabinet Micro-CT Micro-CT
Imaging area 240 × 300 mm 100 × 150 mm 120 × 140 mm 120 × 120 × 30 mm 140-mm diameter
200-mm length
Resolution 21 lp/mm (24.1 μm) 10 lp/mm (48.2 μm) 7.1 lp/mm 13.5 μm <4 to 5 μm, 7 to 8 μm
low contrast
Focal spot 10 μm nominal 50 μm 50 μm 40 to 300 μm <5 μm
Energy 5 to 50 kV 20 to 40 kV 20 to 35 kV Up to 50 kV 40 to 130 kV
Scan time 3.6 to 72 s
Reconstruction
time
40 to 150 s
Footprint 53 cm × 38 cm × 170 cm 56 cm × 57 cm × 170 cm 26.5 × 37.5 × 68.3 in: 203 × 163 × 214 cm 107 × 72 × 62.5 cm
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tissue’s nuclear magnetic dipole interactions. Soft tissue
differentiation is the strongest benefit of MRI and it is
more sensitive to breast cancer than x-ray imaging. One
study found a sensitivity of 93% and a specificity of
65%.54–56 MR images are acquired preoperatively with con-
trast injection and are used for surgical planning often to
detect satellite lesions, which extend beyond the main
malignancy.57
Fig. 2 (a) Tumor mass appears far from the margin in 2-D radiography. (b) Micro-CT cross section indi-
cates tumor closer to the edge of the specimen. (c) Histopathology slide shows tumor mass closer to
edge, more similar to the micro-CT slice than the 2-D radiography image.48 The mammography images
are limited to one or two views, while the micro-CT is full volumetric. The whole mount histology is useful
but not routinely done for any lumpectomy specimens, so the value of a micro-CT is to visualize the tumor
extent in all 3-D. Reprinted by permission from Ref. 48, Springer Nature.
Fig. 3 MRI images (left) and the corresponding H&E slides (right). Each is followed by a magnified
version of the portion of the image inside the viewing box superimposed on the lower magnification im-
aging data. Classifications are: (a) normal breast tissue, (b) fibroadenoma, (c) DCIS, (d) invasive ductal
carcinoma and DCIS, and (e) invasive lobular carcinoma.58 The value of MRI is the best soft tissue res-
olution for full volumetric imaging, with high spatial resolution, while the limitation of this has always been
high cost of the systems and long scan times. Adapted from Ref. 58. Creative Commons Attribution
License 4.0, Copyright 2015, Macmillan Publishers Limited.
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One study of MRI applied to resected breast specimens
achieved 59 × 59 × 94 μm3 spatial resolution, albeit with an im-
aging time exceeding hour, which is likely too long for routine
surgical use. In that study, 14 pathologists provided diagnoses
based on the MR images, but achieved the correct results only
36% of the time, and the accuracy of categorizing benign versus
malignant lesions was only 57%. The study pathologists had no
prior MR interpretation training, so their lack of experience
likely affected the results negatively. Although these diagnostic
performances were not very promising, study showed the fea-
sibility of using specimen MRI, intraoperatively. Given the MR
soft tissue contrast available through MRI further study is war-
ranted in the context of specimen imaging. Figure 3 shows a
number of representative cases of different breast tissue diagno-
ses for MR images and their corresponding H&E images.58 The
development of low-medium field, self-shielded MRI scanners,
which present a lower risk, could open up the field to use in the
surgical settings.59 Another study used a high magnetic field
(9.4 T) specimen MRI. This study found that for IDC, MRI
is a very promising form of margin localization. It did note
that for DCIS, this method was far less effective. It also
noted the number of challenges that will make it difficult for
MRI to be adopted into margin assessment in clinical practice
including cost, ease of use, and imaging time, which are all seri-
ous concerns for margin management in BCS.60 MRI is a
common modality for other uses in hospitals so using it for
breast cancer margin detection is attractive since there is likely
already trained staff that knows how to interpret the images. It is
also attractive since it has much better soft tissue contrast than x-
ray imaging does, which is the most common intraoperative
technique for lowering margin rates. However, the long scan
times for MR imaging and the high cost of this technique
make this a nonideal solution to lowering positive margin
rates in BCS.
3.4 Ultrasound
High-frequency ultrasound imaging of the specimen margin
visualizes structural features of the tissue and its associated
heterogeneity. One report of ultrasound (in a range of 20 to
80 MHz) evaluated 34 samples from 17 patients and found
the technique distinguished lobular carcinoma from normal tis-
sue with specificity of 100% and sensitivity of 86%; ductal car-
cinoma from normal tissue with specificity of 100% and
sensitivity of 74%; benign pathologies from cancer with speci-
ficity of 80% and a sensitivity of 82%; and fat necrosis from
adenoma with specificity of 80% and sensitivity of 100%.61
A more recent study of 132 patients reported a sensitivity of
44% and a specificity of 94%. This study notes that US may
be a better alternative to specimen x-ray in cases of dense
breasts, where x-ray has the most difficulty. It also notes how
US is much faster and far less expensive than the more com-
monly used modality of specimen x-ray.62 Advances in ultra-
sound transducers and signal processing continue to be
reported; hence, the value of high-frequency ultrasound to mar-
gin assessment may increase. Improved understanding of the
strengths and weaknesses of this modality in the context of
specimen imaging is needed, and advances such as 3-D ultra-
sound currently being applied to dense breasts could be utilized
for specimen scanning as well.63 Ultrasound guidance for sur-
gical margins provides a tool that can be useful for determining
margin status in a low-cost manner, especially for women with
dense breasts where other methods may not work as well.
However, the necessity of larger margins (up to 10 mm being
considered positive in some studies), low-sensitivity numbers,
and requirement to be scanned make it so ultrasound will likely
not be a full solution to the margin status problem.
3.5 Nuclear Medicine
Nuclear imaging involves administration of radioactive tracers
in vivo, prior to surgery, and obtains diagnostic or treatment
related information, accordingly. The approach provides more
functional rather than structural data since it inherently depends
on blood flow delivery and biological or biophysical uptake of
the agent. This type of breast imaging includes detection of posi-
tron annihilation radiation and Cherenkov optical imaging, and
both have been evaluated for specimen margin assessment.
Although this review is focused on imaging of surgical mar-
gins, many of these techniques can be used to assess sentinel
lymph nodes as well particularly those using nuclear medicine.
The sentinel lymph node is the first drainage site for breast can-
cers and provides information about the metastatic status of the
disease.48,64,65
3.6 Positron Emission Tomography
3.6.1 Customized breast PET
18F-fluorodeoxyglucose is by far the most commonly used
positron emission tomography (PET) agent, and localizes
tumor based on signal intensity. This signal intensity change
is from the increased metabolism of tumors and the resulting
increase of glucose uptake. It can also be used to check the status
of margins. In one study, a preoperative positron emission
tomography/computed tomography (PET/CT) scan was
acquired to characterize tumor. Images guided the resection,
and since the radioactive signal could be detected ex vivo, a
gamma probe assisted in the assurance of clear margins.
Then a full PET/CT scan was performed on the resected tissue
to determine if the amount of tumor removed matched with the
extent of disease observed on preoperative imaging. A final
patient exam was also performed after the surgery to localize
residual tumor, if any. In the study, 18F-fluorodeoxyglucose
uptake was not specific, increasing likelihood of false positive
results. The method has also been used to guide tumor locali-
zation. It is important to note that this has only shown feasibility
since there were only two patients involved in this initial study.64
Breast PET has shown a sensitivity of 92% to 96% and a speci-
ficity of 84% to 91%.66–68 Breast PET shows promise with high
sensitivity and specificity. It is also a modality commonly used
in hospitals for other purposes so there likely is already staff
who know how to interpret the results well. However, PET is
expensive, time-consuming, and invasive which makes it an
unattractive solution to the positive margin percentage problem
in BCS.
3.6.2 Cherenkov PET
Another use of PET in margin status detection is Cherenkov
luminescence imaging (CLI), which captures Cherenkov optical
photons produced by PET agents present in tissue. Cherenkov
photons are generated when charged particles (such as the posi-
trons emitted by PET imaging agents) travel at a velocity faster
than the speed of light in the medium. These emitted Cherenkov
photons can be detected with a range of low-cost cameras or
small detector technologies. The technique is attractive for
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guiding surgical margins, especially if PET imaging is planned
and the imaging agents are already present in the patient.69 This
approach has been used in a study with 18F-fluorodeoxyglucose
(FDG) in human patients for intraoperative breast tumor margin
assessment. Promising results were found in that elevated tumor
radiance was observed at 2.4 times the background tissue, at a
dose of only 10’s of microSv to surgical staff. However, the
study was preliminary (10 patients to optimize the imaging tech-
nique followed by 12 that generated the study results), and deter-
mining the effectiveness of the technique at margin detection
requires further investigation. All 12 margins were negative
based on both CLI and standard histology; hence, no results
on positive margins were reported. Figure 4 shows a represen-
tative case. The Cherenkov signal combined with a greyscale
image is compared to radiography and H&E images. Margin
status was not estimated accurately from the radiography
image due to the presence of a clip.70 The research is continuing
and is being sponsored by LightPoint Medical, Ltd. This tech-
nology shows promise especially since it inherently has all of
the benefits of standard PET imaging with only minimal addi-
tional work. It is a technology for this purpose, so larger studies
are needed to show sensitivity and specificity; it can be assumed
that they will be at least as good as standard PET imaging how-
ever. The drawbacks for CLI imaging are the same as those for
standard PET imaging.
3.7 Electromagnetic Measurements
Electromagnetic measurement exploits portions of the electro-
magnetic spectrum to obtain information about how charge
flows through tissue.71–74 Since biological behavior alters the
electromagnetic properties of tissue, these types of measurement
methods show promise in detecting changes associated with
malignant tumors.
3.7.1 Radiofrequency
Tissues with different structural and molecular characteristics
have different electromagnetic scattering, reflectance, and
absorbance properties. Radiofrequency spectroscopy considers
signals in the radiofrequency range, often delivered by a probe,
to determine if the sampled tissue is malignant or benign. One
system, “MarginProbe” (Dune Medical Devices, Caesarea,
Israel), acquires multiple point measurements from each surface
of a specimen and yields a positive or negative reading for each
location. If the device outputs a positive result for a given sur-
face, the surgeon removes more tissue from the cavity corre-
sponding to the margin. Measurements of a fully excised
lumpectomy require ∼5 min. The accuracy of the probe has
been compared to standard histology on a set of 753 measure-
ments obtained from 76 breast specimens and was found to have
a sensitivity of 70% and a specificity of 70% for all types of
Fig. 4 (a) Cherenkov image of a specimen. White arrows correspond to areas of increased signal where
tumor is visible. (b) Photograph of the specimen combined with the Cherenkov signal. (c) Radiography
image of the same specimen. (d) H&E image that corresponds to the region.70 The use of Cherenkov
matches the need to obtain surface scan data and provides high resolution, while the key limitations
appear to be signal-to-noise possible and the length of the scan time needed. But this modality is in
its early stages and further clinical studies will likely occur as the technology evolves. This research
was originally published in JNM. Adapted from Ref. 70. Copyright SNMMI.
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breast malignancies including DCIS. The approach performed
better on larger regions of cancers near the surface.75 A number
of clinical trials have been completed with the “MarginProbe”
device including the MAST study in Israel, the US Pivotal Study
in the United States, and a multicenter study in Germany.76–78
These studies have led to FDA approval of “MarginProbe” as a
device to help surgeons identify positive margins. A more recent
study of 596 patients where half the surgeries used the
MarginProbe device and half were completed without additional
guidance revealed a significant decrease in the number of re-
excisions necessary.79 Radiofrequency imaging offers the poten-
tial benefit of an easy to use FDA approved tool for lowering
positive margins. However, it also has serious drawbacks of
low sensitivity and specificity and it is based on user-guided
spot scanning.
3.7.2 Bioimpedance spectroscopy
Another technology that guides surgeons to remove the entire
tumor mass is the “ClearEdge”™ (CE) device. It performs bio-
impedance spectroscopy on the resected tissue. Bioimpedance
spectroscopy is sensitive to intra and extracellular changes in
tissue based on alterations in dialectic properties. The CE device
is handheld, portable, and battery powered making it very easy
to use in the OR. It performs a baseline measurement from the
patient’s normal breast in order to evaluate differences in cellu-
larity relative to this norm as an internal control. A study involv-
ing the CE device reported a re-excision rate of 17% with the
system compared to 37% without it as part of the trial. CE com-
pletes a full scan in <5 min, the output of which is either green
for fatty normal, yellow for fibrous normal, or red for tumor/
abnormality, which guides the surgeon to remove more tissue,
if needed. This method produced a sensitivity of between
84.3% and 87.3% and a specificity of 75.6% and 81.9%.80
Bioimpedance spectroscopy is a promising tool due to its fast
scanning, portability, and ease of use. However, it lacks sensi-
tivity and specificity and still has a rather large rate of reoccur-
rence with use.
3.8 Whole Specimen Optical Imaging
Optical methods capture photons to create images. Since pho-
tons at optical wavelengths have shallow penetration into tissue,
they interrogate the surfaces of tissues effectively for margin
analysis, but are limited when assessing internal structures.
Whole specimen optical imaging requires wide-field methods
and usually scans large areas of tissue to achieve multiple cen-
timeters of coverage. These types of imaging systems tend to
have lower spatial resolution than spot sampling, but they
also tend to be much faster and cover larger areas of tissue
per acquisition.
Current standard of care in BCS involves inking a specimen
after removal to maintain specimen orientation during
processing.81 This inking process involves marking each side
of the specimen with a specific color of ink so that if a positive
margin in found histologically the surgeon will know which side
of the cavity to removed tissue from in the re-excision surgery.
The timing of this inking is widely variable from institution to
institution. Some hospitals now have the surgeon ink immedi-
ately after resecting the tissue to preserve orientation while at
some the surgeon will place sutures on the specimen which
would later be inked in the pathology department. Inking
later by the pathologist has been found to be far less accurate
as it is much more difficult to maintain orientation for that period
of time.82,83 One issue that can arise from this inking process is
that these colored inks are highly scattering and absorbing with
optical and NIR light, which can cause many of the techniques
described here to be far less effective. One solution is to use
different dyes, which affect NIR light less.84 Another possibly
easier solution would be carefully increasing the “window
period” between removal of specimen and inking so that optical
techniques can be utilized. During this increased window, the
amount of time between resection and inking is not as important
as very careful handling to maintain orientation to perform ink-
ing after imaging. This is an area of research that must be care-
fully examined when creating protocols for techniques when
they are utilized in clinical settings to not interfere with care.
3.8.1 Photoacoustic tomography
Photoacoustic tomography (PAT) harnesses laser pulses to
deliver focal energy to tissue, the absorption of which releases
ultrasound emissions. This method achieves contrast through
hemoglobin or an exogenous agent and has imaged different
types of biological tissues at reasonable depth and with high-
chemical selectivity. However, it has not been used extensively
for tumor margin detection, since blood-based contrast has not
been found to distinguish tumor from other tissue at the
margin.85 One group added a lipid channel as a second contrast,
since a large fraction of normal breast contains fat, and acquired
data at 16 wavelengths spanning 1100 to 1250 nm. The instru-
ment scanned 4.5 cm2 of tissue per minute at a 3-mm depth and
achieved 125-μm axial resolution, which is sufficient for margin
detection. The device achieved 100% sensitivity in a 12-speci-
men sample set. However, it obtained 75% specificity since
dense connective tissue was evaluated to be tumor. Figure 5
shows an example of photoacoustic images and illustrates
how the contrast of fat to hemoglobin was used to assess
tumor at the margin.86 Although this method shows promise,
large improvement in use and specificity would need to be
Fig. 5 Example of photoacoustic images of a breast specimen:
(a) ultrasound image of the specimen, (b) component 1 shows hemo-
globin contrast, (c) component 2 shows adipose contrast, (d) com-
bined Component 1 and component 2 image, (e) spectra of these
components, and (f) H&E image corresponding to the regions of inter-
est.86 This type of imaging shows some potential for deep tissue infor-
mation albeit at lower spatial resolution than microCT or MRI and
tends to have most ex vivo contrast based upon fat and water con-
centrations. Specificity for cellular or molecular features is uncertain at
this time. Adapted with permission from Ref. 86, OSA Publishing.
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made in order for this technology to be a viable option. The stud-
ies to date have been were done on very small sample sizes and
comparisons between cancer and healthy tissue only worked
well for adipose tissue, not fibroglandular nor connective
tissues.
3.8.2 Spatial frequency domain imaging
SFDI, also known as structured light imaging, projects patterns
of light at different spatial frequencies and wavelengths to assess
the surface of a surgical specimen. Information that can be
obtained includes absorption coefficient, reduced scatter coeffi-
cient, oxygenated hemoglobin concentration, and deoxygenated
hemoglobin concentration.87 These quantities are biologically
relevant to cancer progression. SFDI is also a wide-field process
that acquires information over a large surface area quickly. One
study applied SFDI to quantify optical properties in the NIR
range from 47 lumpectomy specimens. Results distinguished
benign from malignant samples with 93% specificity and
79% sensitivity, and all pathology subtypes that were investi-
gated (fibrocystic disease, fibroadenoma, DCIS, invasive cancer,
and invasive cancer that was treated with neoadjuvant chemo-
therapy) were stratified correctly. Figure 6 shows a representa-
tive sample of spectral maps created for different tissue
categories. For each pathology of tissue present, this figure
shows the different optical parameters calculated and the images
of these parameters. These maps are used to potentially diagno-
sis tissue samples.88 The SFDI process is very fast relative
to other methods, provides wide-field and quantitative images,
and is very cost-effective compared to other methods. However,
it does not provide high-resolution chemical or molecular
information.
3.8.3 Fluorescence imaging
Fluorescence imaging records light emitted by a molecule that
has absorbed energy from another source. Relative to imaging
breast cancer margins, it usually involves injection of a fluoro-
phore preoperatively followed by imaging during surgery or on
the resected specimen. One study considered near-infrared
(NIR) fluorescence imaging with methylene blue based on
the fact that methylene blue should be taken up more in malig-
nant cells and washed out faster in benign tissue. This approach
identified tumors in 20 of 24 (83%) of patients. It was better for
certain types of breast cancers (carcinomas and DCIS) relative to
other subtypes (mucinous). These results are promising but are
based on a small number of cases. Figure 7 shows a represen-
tative example, in which no fluorescence was detected on the
surface of the resected specimen or along the walls of the sur-
gical cavity, but was detected once the specimen was cut and the
Fig. 6 Spectral maps of different tissue types including normal tissue, fibroadenoma, DCIS, invasive
cancer, and invasive cancer postneoadjuvant chemotherapy. Rows include a photograph of the cut
specimen (first row) followed by the corresponding H&E images (second row). Spectral maps of scatter-
ing amplitude and scattering slope are shown in the latter two rows.88 This modality provides wide-field
full-frame imaging capability with multispectral potential to resolve water, lipids, scattering, and hemo-
globin features, at high spatial resolution. The value of this is the high resolution with full optical spectral
sensitivity, while the limitations are the fact that this samples largely the surface of the tissue, and so is
not volumetric. Adapted from Ref. 88. Creative Commons Attribution License 2.0, Copyright BioMed
Central Ltd. .
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tumor was revealed.89 Another NIR fluorophore that is com-
monly used for sentinel lymph node tracing is indocyanine
green.90 Fluorescence margin assessment has been tested using
bevacizumab-IRDye800CW targeting VEGF-A, LUM015, and
ABV-620 with some success.91–93 There are also a number of
label-free fluorescence imaging techniques that may show
promise for use in BCS. One example of this is using autofluor-
escense, which uses the body’s natural emission sources. In
a study of autofluorescense along with diffuse reflectance,
one study of 12 patients with tumor surfaces and 28 patients
with clinically normal surfaces found an 85% sensitivity and
96% specificity.94 Another form of label-free fluorescence is
fluorescence lifetime imaging (FLIM). This method takes mea-
surements over time after excitation and can separate different
fluorophores based on their lifetime. One study using FLIM of
resected tissue from 14 patients was able to achieve sensitivities
and specificities in the high 90%.95 Fluorescence imaging shows
promise as a method for positive-margin reduction due to its
ability to potentially selectively target tumor cells and its ability
for real-time imaging. However, it is one of the more invasive
methods described here since it involves injecting a fluorophore
into the patient and many fluorophores are not selectively tar-
geting in breast tissue.
3.9 Spot Sampling and Microscopic Optical Imaging
Area-sampling optical imaging is similar to whole specimen im-
aging, except that these methods achieve higher spatial resolu-
tion, on the order of cellular features. However, they are usually
much slower and are based on scanning techniques, in which
many images are acquired and stitched together.
3.9.1 Elastic scatter spectroscopy/diffuse reflectance
spectroscopy
Elastic scatter spectroscopy (or diffuse reflectance spectros-
copy) applies pulsed or continuous wave light and collects scat-
tered light from the tissue to generate an optical spectrum. One
study collected data from 24 patients involving 72 biopsies to
classify samples as normal or cancerous. The approach achieved
a sensitivity of 67% to 69% and a specificity of 79% to 85%.
However, the method of margin detection was based on point
measurements and was limited by interference from blood
and/or room lights in this preliminary study.96 This limitation
of interference with room lights was because of the preliminary
nature of this study and has been solved in later studies.97
Both diffuse reflectance spectroscopy and autofluorescence
were captured to assess margin status in a data set consisting of
145 normal spectra from 28 patients and 34 tumor spectra from
12 patients. Results yielded a specificity of 96% and a sensitivity
of 85% for cancer relative to normal tissue. This method pro-
duced a depth sensitivity of about 1 mm for both IDC and
DCIS. This is adequate for invasive cancers according to con-
sensus guidelines but for DCIS a margin of 2 mm is recom-
mended. However, changing the geometries of these systems
could be a way to obtain a greater depth sensitivity.94
Another device was constructed to acquire optical spectral
images of tissue using a box that probed a 1 × 3 cm area.
This device used multiple fibers to scan over the specimen in
order to create an image. From these images, maps of reduced
scatter coefficients and light absorption (total beta-carotene and
hemoglobin) were generated. Ratios of total hemoglobin or
beta-carotene to the reduced scattering were formed in an aver-
age of 25 s per image area. These two ratios were evaluated to
Fig. 7 (a) Resected specimen shows no fluorescent signal, (b) corresponding surgical cavity in which no
fluorescent signal was observed, and (c) sliced specimen which shows fluorescent signal at the tumor
location.89 This approach adds significant value by providing a direct surgical view of the tissue and field,
but requires contrast injection either prior to or during surgery. The exact contrast available is dependent
upon the background tissue and the vascular patency of the tumor and normal tissues. Reprinted with
permission from Ref. 89, Copyright 2014, Elsevier.
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distinguish positive or close margins from a clear margin. The
study yielded a sensitivity of 79.4% and a specificity of 66.7%
on an imaging set of 48 patients and showed that the ratio of
beta-carotene to reduced scatter was a better indicator of margin
status than the hemoglobin to reduced scatter ratio.98 Another
study used diffuse reflectance spectroscopy with two different
models to compare the diagnostic value of each. When using
a Monte Carlo-based model, they were able to achieve a sensi-
tivity of 83% and a specificity of 80%. They also used an empiri-
cal partial least squares model and were able to achieve
a sensitivity of 83% and a specificity of 76%.99
Another study used light with wavelengths between 500 and
1600 nm for diffuse optical spectroscopy on a set of 102 sam-
ples. From these optical measurements, several parameters such
as blood, water, and lipid volume fractions, Mie slope, Mie scat-
ter fraction, reduced scattering amplitude, and pigment packag-
ing factor were computed and analyzed for their diagnostic
power. This study found high sensitivity (between 81% and
98% depending on the tissue type) and high selectivity (95%
to 99%). This study also noted that commonly beta-carotene
is used as an adipose discriminator but that lipid volume fraction
was found to be a better discriminator in this study.100 Diffuse
reflectance spectroscopy offers potentially high specificity and
selectivity and is able to give a significant amount of useful
information about the tissue. However, it is probe based,
which leads to a good potential for user error and can take a
significant amount of time to get an adequate amount of tissue
sampled.
3.9.2 MUSE
Microscopy with UV surface excitation (MUSE) exploits the
low-penetration depth of UV light to excite fluorophores at
the surface of a stained tissue. The approach is relevant to mar-
gin assessment of invasive tissue in BCS, since guidelines
suggest that “tumor on ink”4 is the requirement for a positive
margin in the case of invasive cancers. It is rapid, inexpensive,
and nondamaging to tissue samples and does not require the
steps associated with conventional histology processing, fixing,
embedding, or sectioning. MUSE does use a fluorescence dye to
stain tissue. It is not useful if depth information is necessary
(e.g., when assessing a positive margin for DCIS) since it relies
on the shallow penetration depth of UV light, and as a result
interrogates the surface of the resected specimen.101,102 Since
MUSE is still in its infancy as a technique for breast tumor mar-
gin assessment, large scale studies are required to get sensitivity
and specificity numbers. MUSE offers excellent information for
invasive cancer margin detection but needs further study before
it can be seen as a solution to the positive margin problem.
3.9.3 Light-sheet microscopy
Light-sheet microscopy uses decoupled illumination and collec-
tion beams for fluorescence generation and detection in order to
achieve both rapid imaging of irregular surfaces and depth im-
aging of volumetric samples. A recent study reported the ability
to image a 4-cm2 tissue surface stained in acridine orange in less
than a minute with an open-top light-sheet microscopy system
and obtained similar information to conventional H&E staining
and imaging. Figure 8 shows a representative comparison of
light-sheet microscopy with H&E imaging. This shows how
light-sheet microscopy matches very well with histology and
better than frozen section analysis.103 Light-sheet microscopy
is a technology that has not been applied to a large enough
study yet to obtain sensitivity and specificity measurements.
Light-sheet microscopy provides excellent resolution and infor-
mation about the tissue surface. However, it does this at the
expensive of potentially long scan times and providing too
much information to digest in a surgical environment.
Fig. 8 Images comparing the performance of light-sheet microscopy with histology. Images of different
regions with different magnifications and their corresponding histology images are shown. Results from
frozen-sectioning imaging are also included and suggest improved performance with light-sheet micros-
copy.103 The value of this type of system is the extremely high spatial resolution and the ability to augment
pathology imaging, whereas the limitations here are the fact that the scan times could be lengthy and the
information could be too dense for surgical use. Reprinted by permission from Ref. 103, Springer Nature.
Journal of Biomedical Optics 100901-11 October 2018 • Vol. 23(10)
Maloney et al.: Review of methods for intraoperative margin detection for breast conserving surgery
Downloaded From: https://www.spiedigitallibrary.org/journals/Journal-of-Biomedical-Optics on 26 Jul 2019
Terms of Use: https://www.spiedigitallibrary.org/terms-of-use
3.9.4 Nonlinear microscopy
Several types of nonlinear microscopies are available and
include incoherent nonlinear methods such as two-photon fluo-
rescence as well as coherent nonlinear approaches such as sec-
ond harmonic signal generation or coherent anti-Stokes Raman
scattering.104
One study evaluated 179 specimens from 50 patients to
determine if nonlinear microscopy has merit for intraoperative
margin assessment. Two-photon microscopy was acquired from
samples that were stained with acridine orange for nuclear im-
aging. The approach offered the benefit that data were obtained
on fresh intact samples without a need for sectioning, fixing, or
embedding associated with other methods such as frozen sec-
tioning, although extrinsic staining with acridine orange was
required. Resulting images were false-colored to match closely
the colors that would appear with H&E staining in order to
present familiar information to the pathologist. This false color-
ing used to create these pseudo-H&E slides came from the two-
photon fluorescence from acridine orange for the blue and the
second harmonic generation for the pink areas representing
collagen. Results showed 95.4% sensitivity and 93.3% specific-
ity on average in classifying benign and invasive cancer samples
relative to corresponding H&E diagnoses.105 Figure 9 shows
nonlinear microscopy images acquired from a specimen with
invasive ductal carcinoma and compares them to confocal fluo-
rescence and H&E images. This shows the correlation between
the false-color images created using nonlinear microscopy and
H&E images.106 The study concluded that confocal florescence
microscopy offered similar information to nonlinear microscopy,
but at much lower cost. When magnification was increased sig-
nificantly, a blurring effect did occur with confocal fluorescence
microscopy (CFM); however, nonlinear microscopy offers
molecular information with very strong sensitivity and specificity.
However, its largest drawbacks are its small region sampling lead-
ing to long scan times if large area coverage is wanted and its cost
due to the high cost of the short-pulse lasers used.
3.9.5 Optical coherence tomography
Optical coherence tomography (OCT) applies NIR light to cre-
ate micron-scale images of subsurface tissue structure up to
Fig. 9 Images of the same specimen with invasive ductal carcinoma obtained with CFM, multiphoton
microscopy (MPM), and H&E histology. The left column shows images from CFM, the middle column is
MPM, and the right column is the H&E results. Each row shows a corresponding magnification of the
image data.106 These scans are at the pathology imaging level and so while extremely rich in information,
they provide a better solution for pathologists than for surgical guidance. Adapted with permission from
Ref. 106, SPIE Publishing.
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2 mm below the surface. Data can be produced in real time and
are multidimensional. OCT takes advantage of the highly scat-
tering nature of tumor cells (because of their higher nucleus-to-
cytoplasm ratio) relative to the large, low-scattering behavior of
adipose cells. When used to determine margin status, OCT iden-
tifies regions of highly scattering, heterogeneously scattering,
and tightly packed cells. Cauterized tissue and surface blood
can interfere with OCT; however, these effects are visually ap-
parent on the sample before OCT acquisition. The highly scat-
tering characteristic of cancerous cells and their heterogeneity
can also be distinguished from the low scattering of blood
and cauterized tissue which are largely confined to the surface
of the sample. In a study of 20 patients, OCT yielded a speci-
ficity of 82% and a sensitivity of 100% (9 true positives, 9 true
negatives, 2 false positives, and 0 false negatives) in predicting
margin status of lumpectomy specimens. Dyes do not affect
OCT since they absorb in the lower wavelengths of light; for
example, around 1300 nm in this study. Scans of 1 cm2 surface
regions of tissue can be acquired in seconds with a lateral res-
olution of 35 μm. However, it is worth noting that lumpectomy
sites are usually larger than 1 cm2, so this could take several
minutes to analyze based on how large the sample is and the
amount of time it would take to rotate the sample. OCT can
be used both in the resected specimen and in the surgical cavity.
A representative sample, which includes normal tissue, common
artifacts such as those caused by blood or cauterized tissue, and
tumor is shown in Fig. 10.107 A handheld probe was swept
across a tumor bed or a resected sample similarly to the way
conventional ultrasound is used. Here, data from 35 patients
yielded an average sensitivity of 91.7% and an average speci-
ficity of 92.1% based on image assessments provided by five
trained OCT readers.108 Another study evaluated specimens
from 46 patients at 2 different hospitals with a handheld
OCT probe, which also invoked interferometric synthetic aper-
ture image processing read by three trained physicians. This
study acquired 2191 images of 229 shaved margins obtained
from these patients. The device achieved a sensitivity of 55%
to 65% and a specificity of 68% to 70%.109 OCT images require
a trained reader who must be in the OR at time of surgery, which
is labor-intensive and logistically difficult. There are also com-
panies such as Perimeter Medical which are developing com-
mercial systems for intraoperative OCT.110 OCT offers high
resolution, depth scans in real time, which makes it an attractive
technology for use in lowering the number of positive margins.
However, it has some serious drawbacks including the need for
a trained operator to be present of the surgery and that it is spot
sampling so it requires potentially long times to scan the entire
specimen.
3.9.6 Raman spectroscopy
Raman spectroscopy sources monochromatic light in the visible,
NIR, or near-ultraviolet range to obtain chemical information
about a sample. It exploits the Raman effect or inelastic scatter-
ing of photons to virtual energy states, and their resulting gain or
loss of energy from interactions with vibrational modes of the
material being interrogated. The effect is measured through
shifts in energy caused by the phenomenon. Certain shifts
are known to be associated with specific types of biological
material, which indicates Raman spectroscopy can be very sen-
sitive to the biochemical makeup of tissue. Raman spectroscopy
is very specific to the molecular makeup on the region analyzed;
however, signal intensity is weak. Since these signal levels are
low, data acquisition may need to involve long collection times,
which are nonideal for a surgical setting. Raman spectroscopy
produces information at a subcellular level noninvasively, label-
free and is not contaminated by water. It detected margin status
with 93.3% accuracy on a data set of 31 spectra acquired from 9
patients. Unfortunately, the data set contained only one positive
margin and is limited in this regard. The method also depends on
point measurements and records spectra at a rate of 1 Hz.
Figure 11 shows Raman spectra from this study for normal
breast tissue, fibrocystic change, and DCIS, along with their cor-
responding coefficients.111 Another study developed a probe
that used spatial-offset raman spectroscopy to determine margin
status up to 2 mm below the surface of excised specimens with
95% sensitivity and 100% specificity in 35 samples. However,
the system acquired point measurements which caused the mar-
gin assessments to be laborious and time-intensive.112 Another
study reported results from a device, “Marginbot,” which is an
automated scanning system for the surface of a tissue sample.
The instrument automatically scanned the surface of the sample
using a probe-based system and provided its margin status in
<15 min. It distinguished fibroadenoma from fatty areas of
mastectomy samples with 93% sensitivity and 85% specificity,
but these positive results are yet to be replicated in true lumpec-
tomy specimens since this study used mastectomy samples.113
Raman spectroscopy offers chemical information about the tis-
sue noninvasively, which is a benefit for identifying positive
margins in BCS. However, the technology has large drawbacks
Fig. 10 Representative OCT images of margins from resected tissue samples including: (a) normal tis-
sue, (b) artifacts such as blood, (c) cauterized tissue, and (d) tumor cells at the margin.107 Adapted with
permission from Ref. 107, AACR.
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for BCS including that it is spot-sampling-based and that it
requires long scan times that would likely be too long for
use in a surgical setting.
Another form of Raman scattering is found in Raman-
encoded molecular imaging (REMI), which incorporates nano-
particles that are surface-enhanced Raman-scattering (SERS)
entities that are topically applied to specimen surfaces. One
study evaluated both targeted and nontargeted SERS nanopar-
ticles and their concentration ratios to determine the presence of
malignancy at the tissue surface. Four biomarkers, HER2, mER,
EGFR, and CD44, were considered. Tissue was stained, rinsed,
and raster scanned to create an image that was spectrally demul-
tiplexed in about 10 to 15 min. Sensitivity of 89.3% and speci-
ficity of 92.1% were found based on over-expression of one or
more of these biomarkers. This imaging method is only appli-
cable to the tissue surface, thus, it is not able to tell if margins are
clear 2 mm below the surface for DCIS.114 REMI is attractive as
a technology for use in identifying positive margins since it
gives relevant biological information in these biomarkers. It
does suffer from the need for use of applied nanoparticles
and long scan times.
4 Discussion
Table 2 lists each of the techniques discussed in this review and
how they compare based on common clinical and technical
concerns. Each technique offers benefits and pitfalls. These
rankings are based upon each modality’s strengths and weak-
nesses as discussed based on the literature cited earlier. The
scores and weights reflect a consensus statement by the authors
of this paper. Some of the criteria are more subjective than
others. The best approaches according to Table 2 criteria appear
to be SFDI, bioimpedance spectroscopy, and radiofrequency.
The best method for imaging the interior of specimens to discern
tumor extent is micro-CT. Overall, optical methods show the
most promise because they collect information quickly and
some achieve the penetration depths required to meet current
consensus definitions of clear margins.
It may be important to note that although the focus of this
review is on techniques which take measurements of resected
tissue, it is possible to use some of these techniques directly
on the cavity wall in vivo. This comes with both benefits and
pitfalls. The largest benefit would be that if imaging the tumor
bed, the surgeon can immediately remove the exact area where
the malignancy is rather than basis the resecting on where on the
removed tissue contains a positive margin. A rather large draw-
back of this is that the conditions for measuring are far less able
to be controlled such as background lighting and blood. Cavity
walls are unable to be registered with pathology as well, unless
extra tissue is removed after measurement.
4.1 Hybrid Systems
Systems that incorporate multiple types of complementary im-
aging to yield a more complete picture of the resected tissue may
offer more complete advantages. An example might be a radio-
graphic system used to obtain 3-D image data on internal struc-
ture and tumor confirmation inside the resected specimen tissue,
combined with an optical system to gain more detailed image
data on surface margins. Radiological systems tend not to be
very accurate in assessing tumor at specimen surfaces while
optical systems often have limited penetration depth and provide
less information about the interior of the tissue. Another hybrid
approach might be one where a system provides interior imaging
that guides application of a second, specific, high-accuracy
approach, which involves more time and effort to use. For exam-
ple, combining a wide-field imaging approach with a point
assessment system to yield new information is an appealing
strategy. According to Table 2, the best system for assessing
the specimen interior and tissue volume is micro-CT, whereas
the best systems for evaluating the tissue surface are SFDI, spec-
tral imaging, and radiofrequency imaging. Figure 12 shows an
example of a hybrid system that combines SFDI with a micro-
CT scanner. This pair may be ideal because each subsystem pro-
vides complementary information. Micro-CT provides tumor
confirmation and localization and guides localization of the
SFDI acquisition, which offers much better information on mar-
gin status at the surface of the specimen.
5 Conclusions
Significant clinical need exists for better margin detection intra-
operatively because 15% to 35% of BCS patients need a second
surgery to remove more tissue when a positive margin is found.
Several methods are available that are already part of standard-
of-care but they all have significant clinical and technical lim-
itations that have precluded wide-spread adoption. A number of
methods are being investigated to meet the clinical need better.
This paper reviewed a number of these approaches and com-
pares them in terms of clinical and technical criteria. Based
on these comparisons, the most promising techniques for margin
detection are optical methods based on their rapid acquisition of
image data, nondestructive characteristics, and penetration
depths sufficient to meet consensus guidelines for establishing
clear margins in BCS.
Technologies to determine margin status have been devel-
oped to have high sensitivity and selectivity. However, no cur-
rent modality has matured into a complete solution to the margin
Fig. 11 Raman spectra and fit coefficients for (a) normal breast tis-
sue, (b) fibrocystic change, and (c) DCIS.111 The use of Raman has
progressed to mapping, but the low-signal levels have limited to point
sampling largely from imaging, and so the major barrier in this area
has been the logistics of application in a time efficient manner to large
specimens. But the attraction to having native molecular specific infor-
mation about the tissue has always been a driving factor in utilizing
this methodology for true molecular specific detection of disease.
Adapted with permission from Ref. 111, AACR.
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problem currently facing BCS. Ideally, a system would be able
to detect malignancy on the surface quickly while keeping false
positive margins low to avoid removing excess tissue. Ideally,
but less importantly, a system would be able to confirm tumor
localization as well as determining margin status. This would
prove that not only is there not tumor on the surface, but also
that the tumor is contained within the resected tissue. The ideal
system would also need to be rapid, low-cost, and easy to use,
with sensitivity near 95% and specificity near 85%. As technol-
ogies evolve, they will have to be tested in appropriate single-
center then multicenter trials to confirm their performance
metrics.
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